12,202
Total Claims
$1.9M
Drug Cost
1,674
Beneficiaries
$1,132
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-26%
Cost per patient vs peers
$1,132 vs $1,524 avg
+1%
Brand preference vs peers
13.8% vs 13.7% avg
Brand vs Generic
86% generic
Brand: 1,687 claims · $1.6M
Generic: 10,515 claims · $276K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 495 | $507K |
| Apixaban | 416 | $449K |
| Sacubitril/Valsartan | 278 | $346K |
| Empagliflozin | 85 | $110K |
| Ticagrelor | 94 | $82K |
| Ranolazine | 474 | $60K |
| Dronedarone Hcl | 38 | $40K |
| Evolocumab | 37 | $26K |
| Isosorbide Dinitrate | 302 | $25K |
| Metoprolol Succinate | 909 | $18K |
| Clopidogrel Bisulfate | 945 | $15K |
| Carvedilol | 1,350 | $15K |
| Icosapent Ethyl | 29 | $15K |
| Atorvastatin Calcium | 671 | $11K |
| Lisinopril | 744 | $8,538 |
Prescribing Profile
61
Unique Drugs
$1.4M
Patient Profile
73
Avg Age
53%
Female
1.77
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data